We are honored to announce Dr. Hazel Dockrell, Professor of Immunology at the London School of Hygiene and Tropical Medicine, U. of London, as a featured speaker at the 2nd International Virtual Conference on Frontiers in TB & Mycobacteriology.
Prof. Dockrell is an internationally respected leader in TB immunology, with decades of experience spanning basic, translational, and clinical research. Her work has been instrumental in advancing our understanding of host immune responses to Mycobacterium tuberculosis, particularly in the context of vaccine development and evaluation. She has played key roles in major international TB research consortia to accelerate the development of TB vaccines and diagnostic tools for tuberculosis.
Prof. Dockrell will detail the evolving landscape of human biomarkers used to assess protective immunity in TB vaccine trials. The talk will highlight immune signatures associated with reduced TB risk, insights from recent clinical studies, and the challenges of validating biomarkers across diverse populations and trial settings. She will also discuss how robust correlates of protection can improve trial design, enable earlier decision-making, and accelerate the development of effective TB vaccines.
Join global researchers, clinicians, and public-health leaders as we explore advances shaping the future of TB prevention.
Register now and be part of this important global conversation!
Date: March 2–3, 2026
Time/zone: 8am-3:30pm /eastern time, USA
This conference is organized by Impact Research Communications (IRC)
More info: https://tb.ircconferences.net/ | Frontiers in TB & Mycobacteriology
